INS and Hypoglycemia: The quick lowering effect on blood glucose as well as the super tolerance to glucose challenge in anti-CD3 treated mice suggests that anti-CD3 treatment might have enhanced β cell function in secreting insulin thereby leading to hypoglycemia.